Analystreport

UroGen Pharma Ltd. (NASDAQ: URGN) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating.

UroGen Pharma Ltd. - Ordinary Shares  (URGN) 
Last urogen pharma ltd. - ordinary shares earnings: 3/2 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.urogen.com